The global insulin delivery devices market size was USD 18.63 billion in 2023, estimated at USD 19.84 billion in 2024 and is anticipated to reach around USD 37.02 billion by 2034, expanding at a CAGR of 6.44% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Insulin Delivery Devices Market
5.1. COVID-19 Landscape: Insulin Delivery Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Insulin Delivery Devices Market, By Type
8.1. Insulin Delivery Devices Market, by Type, 2024-2033
8.1.1. Insulin Pumps
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Insulin Pens
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Insulin Pen needles
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Insulin Jet Injectors
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Insulin Delivery Devices Market, By Application
9.1. Insulin Delivery Devices Market, by Application, 2024-2033
9.1.1. Type I Diabetes
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Type II Diabetes
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Insulin Delivery Devices Market, By End User
10.1. Insulin Delivery Devices Market, by End User, 2024-2033
10.1.1. Home Care
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Hospitals & clinics
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Insulin Delivery Devices Market, By Distribution Channels
11.1. Insulin Delivery Devices Market, by Distribution Channels, 2024-2033
11.1.1. Online Sales
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Hospital Pharmacies
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Retail Pharmacies
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Insulin Delivery Devices Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2033)
12.1.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.3. Market Revenue and Forecast, by End User (2021-2033)
12.1.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)
Chapter 13. Company Profiles
13.1. Novo Nordisk A/S
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Wockhardt Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Medtronic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche, Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Abbott Laboratories
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Sanofi
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Eli Lilly and Company
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Biocon Ltd.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ypsomed AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Becton, Dickinson and Company
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample